|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.025 USD | +2.36% |
|
+9.18% | -18.61% |
| Apr. 18 | Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing | MT |
| Apr. 16 | Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer | MT |
Recursion Pharmaceuticals, Inc.(NasdaqGS:RXRX) added to S&P Biotechnology Select Industry Index
| 1st Jan change | Capi. | |
|---|---|---|
| -18.61% | 1.87B | |
| -1.81% | 103B | |
| +0.58% | 95.71B | |
| +1.69% | 22.02B | |
| -17.46% | 20.9B | |
| -9.30% | 17.85B | |
| -41.01% | 16.21B | |
| -14.91% | 15.52B | |
| +3.84% | 13.86B | |
| +35.73% | 12.04B |
RECURSION PHARMACEUTICALS, INC. 
